Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals
The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.
Real-time market intelligence across asset classes
Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.
| Insider | Role | Date | Type | Value |
|---|---|---|---|---|
| LILLY ENDOWMENT, INC. | Shareholder | Jul 07 '26 | Proposed Sale | 372018600.0 |
| LILLY ENDOWMENT, INC. | Shareholder | Jun 26 '26 | Proposed Sale | 343945450.0 |
| Yuffa Ilya | EVP&Pres, LLY … | Jun 10 '26 | Sale | 2876925.0 |
| Yuffa Ilya | Officer | Jun 10 '26 | Proposed Sale | 2876925.0 |
| LILLY ENDOWMENT, INC. | Shareholder | May 28 '26 | Proposed Sale | 335705200.0 |
| LILLY ENDOWMENT, INC. | Shareholder | May 22 '26 | Proposed Sale | 312495000.0 |
| LILLY ENDOWMENT, INC. | Shareholder | May 20 '26 | Proposed Sale | 311530050.0 |
| LILLY ENDOWMENT INC | Former 10% … | May 06 '26 | Sale | 15754537.0 |
| LILLY ENDOWMENT, INC. | Shareholder | May 06 '26 | Proposed Sale | 296661000.0 |
| Zakrowski Donald A | SVP, Finance, … | Feb 16 '26 | Option Exercise | 0.0 |
Source: FinViz — Data may be delayed
AI-curated news influencing LLY price, sentiment, and trend
The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.
Eli Lilly and Company (NYSE:LLY) is one of the 10 Strong Buy S&P 500 Stocks to Invest In. On May …
FEATURE Shares of Eli Lilly rose sharply on Thursday after the drugmaker delivered a beat-and-raise quarter driven partly by demand …
Eli Lilly currently trades at $926.10 and has been a dream stock for shareholders. It’s returned 386% since April 2021, …
Its first weight-loss pill was just approved by the FDA.
Global pharmaceutical companies are aggressively searching for new medicines in China
Multi-Provider AI Analysis